Skip to main content
Fig. 3 | World Journal of Surgical Oncology

Fig. 3

From: Expression of activated signal transducer and activator of transcription-3 as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma

Fig. 3

Kaplan–Meier curves showing median overall survival (mOS) for 153 metastasis esophageal cancer patients treated with paclitaxel and cisplatin according to p-STAT3 levels. The median overall survival was significantly higher in patients with p-STAT3 negative tumors than in those with p-STAT3-positive tumors (9.9 vs 8.9 months, HR 1.112, 95 % CI 0.4305 to 1.794, p = 0.026)

Back to article page